Cercador de Publicacions La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts. Fulltext search Alfabètic A-Z Alfabètic Z-A A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. PMID: 36271011 Revista: Nature Communications Any: 2022 Referència: Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Arribas, Ivan; Di Lernia, Davide; Diaz-Beveridge, Roberto; Gutierrez, Antonio; Hindi, Nadia; Ledesma, Patricio; Lopez-Martin, Jose Antonio; Lopez-Pousa, Antonio; Luna, Pablo; Marcilla, David et al. DOI: 10.1038/s41467-022-33975-6 A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer. PMID: 35034502 Revista: Future Oncology Any: 2022 Referència: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17. Factor d'impacte: 3.404 Tipus de publicació: Article en revista internacional Autors: McGregor, Bradley, Agarwal, Neeraj, Azad, Arun, Carles, Joan, Chowdhury, Simon, Saad, Fred, Soares, Andrey, Benzaghou, Fawzi, Kerloeguen, Yannick, Kimura, Akiko et al. DOI: 10.2217/fon-2021-1096 A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer. PMID: 35034502 Revista: Future Oncology Any: 2022 Referència: Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Agarwal, Neeraj; Azad, Arun; Benzaghou, Fawzi; Carles, Joan; Chowdhury, Simon; Kerloeguen, Yannick; Kimura, Akiko; McGregor, Bradley; Merseburger, Axel S; Mohamed, Nehal et al. DOI: 10.2217/fon-2021-1096 A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia. PMID: 35045765 Revista: LEUKEMIA & LYMPHOMA Any: 2022 Referència: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19. Factor d'impacte: 3.28 Tipus de publicació: Article en revista internacional Autors: Willis, Jenna C, Buske, Christian, Perretti, Thomas, Katz, Pablo, Hamidi, Habib, Bottos, Alessia, Panayiotidis, Panayiotis, Tumyan, Gayane, Thieblemont, Catherine, Ptushkin, Vadim V et al. DOI: 10.1080/10428194.2021.2015765 A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia. PMID: 35045765 Revista: LEUKEMIA & LYMPHOMA Any: 2022 Referència: Leuk Lymphoma. 2022 May;63(5):1058-1069. doi: 10.1080/10428194.2021.2015765. Epub 2022 Jan 19. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Bottos, Alessia; Buske, Christian; Garcia-Sanz, Ramon; Hamidi, Habib; Katz, Pablo; Le Gouill, Steven; Marin-Niebla, Ana; Panayiotidis, Panayiotis; Perretti, Thomas; Ptushkin, Vadim V et al. DOI: 10.1080/10428194.2021.2015765 A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. PMID: 34950754 Revista: Bone reports Any: 2022 Referència: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun. Factor d'impacte: 0 Tipus de publicació: Article en revista internacional Autors: Chaverri, Daniel; Vivas, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vives, Joaquim et al. DOI: 10.1016/j.bonr.2021.101157 A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. PMID: 34950754 Revista: Bone reports Any: 2022 Referència: Bone Rep. 2021 Dec 9;16:101157. doi: 10.1016/j.bonr.2021.101157. eCollection 2022 Jun. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Chaverri, Daniel; Gallardo-Villares, Santiago; Granell-Escobar, Fernando; Pinto, Javier A; Vivas, Daniel; Vives, Joaquim et al. DOI: 10.1016/j.bonr.2021.101157 A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype. PMID: 35872910 Revista: Frontiers in Cardiovascular Medicine Any: 2022 Referència: Front Cardiovasc Med. 2022 Jul 8;9:940696. doi: 10.3389/fcvm.2022.940696. eCollection 2022. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Alvarez-Sabin, Jose; Arenillas, Juan Francisco; Blay, Natalia; Campos, Francisco; Camps-Renom, Pol; Carcel-Marquez, Jara; Castillo, Jose; Cruchaga, Carlos; Cullell, Natalia; de Cid, Rafael et al. DOI: 10.3389/fcvm.2022.940696 A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. PMID: 35309285 Revista: International Journal of Chronic Obstructive Pulmonary Disease Any: 2022 Referència: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022. Factor d'impacte: 3.355 Tipus de publicació: Article en revista internacional Autors: Miravitlles, Marc, Verhamme, Katia, Calverley, Peter M A, Dreher, Michael, de la Hoz, Alberto, Wedzicha, Jadwiga, Price, David, Gardev, Asparuh, Bayer, Valentina et al. DOI: 10.2147/COPD.S350167 A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid. PMID: 35309285 Revista: International Journal of Chronic Obstructive Pulmonary Disease Any: 2022 Referència: Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Bayer, Valentina; Calverley, Peter M A; de la Hoz, Alberto; Dreher, Michael; Gardev, Asparuh; Miravitlles, Marc; Price, David; Verhamme, Katia; Wedzicha, Jadwiga et al. DOI: 10.2147/COPD.S350167 A pragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solutions in open fractures (Aqueous-PREP): statistical analysis plan. PMID: 36096826 Revista: Trials Any: 2022 Referència: Trials. 2022 Sep 12;23(1):772. doi: 10.1186/s13063-022-06541-0. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Abbott, Harper; Acerboni-Flores, Francesc; Achor, Timothy S; Adams, John D; Ahn, James S; Al-Asiri, Jamal; Alavedra-Massana, Anna; Alnasser, Ahmad; Altman, Kyle M; Amirhekmat, Arya et al. DOI: 10.1186/s13063-022-06541-0 A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas. PMID: 36970055 Revista: Cancer research communications Any: 2022 Referència: Cancer Res Commun. 2022 Nov 2;2(11):1326-1333. doi: 10.1158/2767-9764.CRC-22-0072. eCollection 2022 Nov. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Borazanci, Erkut; Garcia-Carbonero, Rocio; Garrido-Laguna, Ignacio; Grossman, Joseph E; Hidalgo, Manuel; Huang, Xin; Kern, Kenneth; Laheru, Daniel; Lim, Kian-Huat; Lowy, Andrew M et al. DOI: 10.1158/2767-9764.CRC-22-0072 A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease. PMID: 35124293 Revista: Transplantation and cellular therapy Any: 2022 Referència: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4. Factor d'impacte: 0 Tipus de publicació: Article en revista internacional Autors: Kitko, Carrie L; Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Lawitschka, Anita et al. DOI: 10.1016/j.jtct.2022.01.025 A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease. PMID: 35124293 Revista: Transplantation and Cellular Therapy Any: 2022 Referència: Transplant Cell Ther. 2022 May;28(5):261.e1-261.e7. doi: 10.1016/j.jtct.2022.01.025. Epub 2022 Feb 4. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Abdel-Azim, Hisham; Carpenter, Paul A; Dalle, Jean-Hugues; Diaz-de-Heredia, Cristina; Gaspari, Stefania; Gennery, Andrew R; Handgretinger, Rupert; Kitko, Carrie L; Lawitschka, Anita et al. DOI: 10.1016/j.jtct.2022.01.025 A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study. PMID: 35267436 Revista: Cancers Any: 2022 Referència: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128. Factor d'impacte: 6.639 Tipus de publicació: Article en revista internacional Autors: Davies, Andrew, Cinieri, Saverio, Dupoiron, Denis, Espana Fernandez, Sofia, Leclerc, Johan, Montesarchio, Vincenzo, Mystakidou, Kyriaki, Serna, Judith, Tack, Jan, On Behalf Of The Nacasy Study Group et al. DOI: 10.3390/cancers14051128 A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation-The NACASY Study. PMID: 35267436 Revista: Cancers Any: 2022 Referència: Cancers (Basel). 2022 Feb 23;14(5). pii: cancers14051128. doi: 10.3390/cancers14051128. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Cinieri, Saverio; Davies, Andrew; Dupoiron, Denis; Espana Fernandez, Sofia; Leclerc, Johan; Montesarchio, Vincenzo; Mystakidou, Kyriaki; On Behalf Of The Nacasy Study Group; Serna, Judith; Tack, Jan et al. DOI: 10.3390/cancers14051128 A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. PMID: 33653674 Revista: European Urology Oncology Any: 2022 Referència: Eur Urol Oncol. 2022 Aug;5(4):460-463. doi: 10.1016/j.euo.2021.02.005. Epub 2021 Feb 27. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Celma, Anna; Morote, Juan; Planas, Jacques; Regis, Lucas; Salazar, Aina; Santamaria, Anna; Trilla, Enrique et al. DOI: 10.1016/j.euo.2021.02.005 A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial). PMID: 36335783 Revista: EUROPEAN JOURNAL OF CANCER Any: 2022 Referència: Eur J Cancer. 2022 Dec;177:154-163. doi: 10.1016/j.ejca.2022.09.037. Epub 2022 Oct 14. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Aranda, E; Aranda, Enrique; Argiles; Argiles, Guillem; Argiles, Guillem; Argiles, Guillem; Benavides, M; Benavides, Manuel; Bennouna, J; Bennouna, Jaafar et al. DOI: 10.1016/j.ejca.2022.09.037 A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation. PMID: 34587371 Revista: AMERICAN JOURNAL OF TRANSPLANTATION Any: 2022 Referència: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18. Factor d'impacte: 8.086 Tipus de publicació: Article en revista internacional Autors: Knoop, Christiane; Jaksch, Peter; Parmar, Jasvir; Ussetti, Piedad; Sole, Amparo; Muller-Quernheim, Joachim; Kessler, Romain; Wirtz, Hubert; Boerner, Gerhard; Denk, Oliver et al. DOI: 10.1111/ajt.16858 A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation. PMID: 34587371 Revista: AMERICAN JOURNAL OF TRANSPLANTATION Any: 2022 Referència: Am J Transplant. 2022 Jan;22(1):222-229. doi: 10.1111/ajt.16858. Epub 2021 Oct 18. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Behr, Juergen; Boerner, Gerhard; Denk, Oliver; Ghiani, Alessandro; Jaksch, Peter; Kessler, Romain; Kneidinger, Nikolaus; Knoop, Christiane; Monforte, Victor; Muller-Quernheim, Joachim et al. DOI: 10.1111/ajt.16858 A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer. PMID: 35403447 Revista: THYROID Any: 2022 Referència: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027. Factor d'impacte: 6.568 Tipus de publicació: Article en revista internacional Autors: Badiu, Corin, Robinson, Bruce, Hughes, Brett G M, Keam, Bhumsuk, Parnis, Francis, Elisei, Rossella, Gajate, Pablo, Gan, Hui K, Kapiteijn, Ellen, Locati, Laura et al. DOI: 10.1089/thy.2022.0027 A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer. PMID: 35403447 Revista: THYROID Any: 2022 Referència: Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Badiu, Corin; Capdevila, Jaume; Elisei, Rossella; Faoro, Leonardo; Gajate, Pablo; Gan, Hui K; Hughes, Brett G M; Isaev, Pavel; Jarzab, Barbara; Kapiteijn, Ellen et al. DOI: 10.1089/thy.2022.0027 A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. PMID: 34459702 Revista: LEUKEMIA & LYMPHOMA Any: 2022 Referència: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. Factor d'impacte: 3.28 Tipus de publicació: Article en revista internacional Autors: Canales, Miguel Angel; Lopez-Guillermo, Armando; Tomas, Jose Francisco; Briones, Javier; Martin Garcia-Sancho, Alejandro; Sancho, Juan Manuel; Moraleda, Jose Maria; Terol, Maria Jose; Salar, Antonio; Palomera, Luis et al. DOI: 10.1080/10428194.2021.1971216 A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. PMID: 34459702 Revista: LEUKEMIA & LYMPHOMA Any: 2022 Referència: Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. Factor d'impacte: Tipus de publicació: Article en revista internacional Autors: Bargay, Joan; Briones, Javier; Canales, Miguel Angel; Conde, Eulogio; Deben, Guillermo; Dlouhy, Ivan; Ferrer, Secundino; Garcia Marco, Jose A; Gardella, Santiago; Hernandez, Miguel T et al. DOI: 10.1080/10428194.2021.1971216 Paginació Primera pàgina « Primer Pàgina anterior ‹ Anterior … Page 131 Page 132 Page 133 Page 134 Pàgina actual 135 Page 136 Page 137 Page 138 Page 139 … Pàgina següent Següent › Última pàgina Últim »
